Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Clinical trial NCT04536350 · TERMINATED

Trial details

NCT number: NCT04536350
Sponsor: Prof. Dr. Jörg Leuppi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Corona Virus Infection ARDS Aviptadil

Start date: 2021-05-18
Primary completion: 2023-06-14
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.